Top

Journal of Endocrinological Investigation

Published in:

01-09-2014 | Review

Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid

Authors: Hossein Hosseinzadeh, Marjan Nassiri-Asl

Published in: Journal of Endocrinological Investigation | Issue 9/2014

Abstract

Background

In recent years, flavonoids have been revealed to be helpful in the treatment of many diseases. Rutin (3,3′,4′,5,7-pentahydroxyflavone-3-rhamnoglucoside) is an important flavonoid that is consumed in the daily diet. It is also known as vitamin P and quercetin-3-O-rutinoside. In addition, it is found in many food items, vegetables, and beverages. The cytoprotective effects of rutin, including gastroprotective, hepatoprotective, and anti-diabetic effects, have been shown in several studies. Furthermore, rutin has several pharmacological effects such as anti-inflammatory and anti-glycation activities.

Aim

This work reviewed characteristic, pharmacokinetic, and metabolic effects of rutin in all experimental and human studies.

Conclusions

Based on the above summarized effects of rutin, this flavonoid appears to be a potent component that could be considered in the treatment of several gastrointestinal diseases and diabetes.

Fabjan N, Rode J, Kosir IJ, Wang Z, Zhang Z, Kreft I (2003) Tartary buckwheat (Fagopyrum tataricum Gaertn.) as a source of dietary rutin and quercitrin. J Agric Food Chem 51:6452–6455CrossRefPubMed

Kreft S, Knapp M, Kreft I (1999) Extraction of rutin from buckwheat (Fagopyrum esculentum Moench) seeds and determination by capillary electrophoresis. J Agric Food Chem 47:4649–4652CrossRefPubMed

Kuntić V, Pejić N, Ivković B et al (2007) Isocratic RP-HPLC method for rutin determination in solid oral dosage forms. J Pharm Biomed Anal 43:718–721CrossRefPubMed

Gulpinar AR, Orhan IE, Kan A, Senol FS, Celik SA, Kartal M (2012) Estimation of in vitro neuroprotective properties and quantification of rutin and fatty acids in buckwheat (Fagopyrum esculentum Moench) cultivated in Turkey. Food Res Int 46:536–543CrossRef

Ghiasi M, Taheri S, Tafazzoli M (2010) Dynamic stereochemistry of rutin (vitamin P) in solution: theoretical approaches and experimental validation. Carbohydr Res 345:1760–1766CrossRefPubMed

Kröner A, Marnet N, Andrivon D, Val F (2012) Nicotiflorin, rutin and chlorogenic acid: phenylpropanoids involved differently in quantitative resistance of potato tubers to biotrophic and necrotrophic pathogens. Plant Physiol Biochem 57:23–31CrossRefPubMed

Manach C, Morand C, Texier O (1995) Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 125:1911–1922PubMed

Nakayama T, Yamada M, Osawa T, Kawakishi S (1993) Suppression of active oxygen-induced cytotoxicity by flavonoids. Biochem Pharmacol 45:265–267CrossRefPubMed

Cervantes-Laurean D, Schramm DD, Jacobson EL, Halaweish I, Bruckner GG, Boissonneault GA (2006) Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nutr Biochem 17:531–540CrossRefPubMed

10.

Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001–1043CrossRefPubMed

11.

Manach C, Morand C, Demigné C, Texier O, Régérat F, Rémésy C (1997) Bioavailability of rutin and quercetin in rats. FEBS Lett 409:12–16CrossRefPubMed

12.

Morand C, Manach C, Crespy V, Remesy C (2000) Respective bioavailability of quercetin aglycone and its glycosides in a rat model. BioFactors 12:169–174CrossRefPubMed

13.

Carbonaro M, Grant G (2005) Absorption of quercetin and rutin in rat small intestine. Ann Nutr Metab 49:178–182CrossRefPubMed

14.

Erlund I, Kosonen T, Alfthan G (2000) Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 56:545–553CrossRefPubMed

15.

Schwedhelm E, Maas R, Troost R, Böger RH (2003) Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clin Pharmacokinet 42:437–459CrossRefPubMed

16.

Jaganath IB, Mullen W, Edwards CA, Crozier A (2006) The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man. Free Radic Res 40:1035–1046CrossRefPubMed

17.

Caillet S, Yu H, Lessard S, Lamoureux G, Ajdukovic D, Lacroix M (2007) Fenton reaction applied for screening natural antioxidants. Food Chem 100:542–552CrossRef

18.

Katsube T, Imawaka N, Kawano Y, Yamazaki Y, Shiwaku K, Yamane Y (2006) Antioxidant flavonol glycosides in mulberry (Morus alba L.) leaves isolated based on LDL antioxidant activity. Food Chem 97:25–31CrossRef

19.

Ziaee A, Zamansoltani F, Nassiri-Asl M, Abbasi E (2009) Effects of rutin on lipid profile in hypercholesterolaemic rats. Basic Clin Pharmacol Toxicol 104:253–258CrossRefPubMed

20.

Kappel VD, Zanatta L, Postal BG, Silva FR (2013) Rutin potentiates calcium uptake via voltage-dependent calcium channel associated with stimulation of glucose uptake in skeletal muscle. Arch Biochem Biophys 532:55–60CrossRefPubMed

21.

Hunyadi A, Martins A, Hsieh TJ, Seres A, Zupkó I (2012) Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats. PLoS One 7:e50619PubMedCentralCrossRefPubMed

22.

Panchal SK, Poudyal H, Arumugam TV, Brown L (2011) Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. J Nutr 141:1062–1069CrossRefPubMed

23.

Elosta A, Ghous T, Ahmed N (2012) Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications. Curr Diabetes Rev 8:92–108CrossRefPubMed

24.

Ansari NA, Rasheed Z (2010) Non-enzymatic glycation of proteins: from diabetes to cancer. Biomed Khim 56:168–178PubMed

25.

Odetti PR, Borgoglio A, De Pascale A, Rolandi R, Adezati L (1990) Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin. Diabetes 39:796–801CrossRefPubMed

26.

Nagasawa T, Tabata N, Ito Y, Nishizawa N, Aiba Y, Kitts DD (2003) Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative. Mol Cell Biochem 249:3–10CrossRefPubMed

27.

Pashikanti S, de Alba DR, Boissonneault GA, Cervantes-Laurean D (2010) Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products. Free Radic Biol Med 48:656–663CrossRefPubMed

28.

Muthenna P, Akileshwari C, Saraswat M, Bhanuprakash Reddy G (2012) Inhibition of advanced glycation end-product formation on eye lens protein by rutin. Br J Nutr 107:941–949CrossRefPubMed

29.

La Casa C, Villegas I, La de Alarcón Lastra C, Motilva V, Martín Calero MJ (2000) Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J Ethnopharmacol 71:45–53CrossRefPubMed

30.

Abdel-Raheem IT (2010) Gastroprotective effect of rutin against indomethacin-induced ulcers in rats. Basic Clin Pharmacol Toxicol 107:742–750CrossRefPubMed

31.

Carrasco-Pozo C, Mizgier ML, Speisky H, Gotteland M (2012) Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells. Chem Biol Interact 195:199–205CrossRefPubMed

32.

Kim H, Kong H, Choi B et al (2005) Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm Res 22:1499–1509CrossRefPubMed

33.

Cruz T, Gálvez J, Ocete MA, Crespo ME, de Sánchez Medina L-HF, Zarzuelo A (1998) Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci 62:687–695CrossRefPubMed

34.

Rabišková M, Bautzová T, Gajdziok J et al (2012) Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation. Int J Pharm 422:151–159CrossRefPubMed

35.

Kwon KH, Murakami A, Tanaka T, Ohigashi H (2005) Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol 69:395–406CrossRefPubMed

36.

Liu Y, Gou L, Fu X, Li S, Lan N, Yin X (2013) Protective effect of rutin against acute gastric mucosal lesions induced by ischemia-reperfusion. Pharm Biol 51:914–919CrossRefPubMed

37.

Domitrović R, Jakovac H, Vasiljev Marchesi V et al (2012) Differential hepatoprotective mechanisms of rutin and quercetin in CCl(4)-intoxicated BALB/cN mice. Acta Pharmacol Sin 33:1260–1270CrossRefPubMed

38.

Wu CH, Lin MC, Wang HC, Yang MY, Jou MJ, Wang CJ (2011) Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells. J Food Sci 76:T65–T72CrossRefPubMed

39.

Duke JA (1992) Handbook of phytochemical constituents of GRAS herbs and other economic plants. CRC Press, Boca Raton

40.

Kamalakkannan N, Stanely Mainzen Prince P (2006) Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol Cell Biochem 293:211–219CrossRefPubMed

41.

Kamalakkannan N, Prince PS (2006) Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin Pharmacol Toxicol 98:97–103CrossRefPubMed

42.

Kamalakkannan N, Stanely Mainzen Prince P (2006) The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney. J Pharm Pharmacol 58:1091–1098CrossRefPubMed

43.

Fernandes AA, Novelli EL, Okoshi K et al (2010) Influence of rutin treatment on biochemical alterations in experimental diabetes. Biomed Pharmacother 64:214–219CrossRefPubMed

44.

Rauter AP, Martins A, Borges C et al (2010) Antihyperglycaemic and protective effects of flavonoids on streptozotocin-induced diabetic rats. Phytother Res 24:S133–S138CrossRefPubMed

45.

Hao HH, Shao ZM, Tang DQ et al (2012) Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Life Sci 91:959–967CrossRefPubMed

46.

Krishna KM, Annapurna A, Gopal GS et al (2005) Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 83:343–355CrossRefPubMed

47.

Je HD, Shin CY, Park SY et al (2002) Combination of vitamin C and rutin on neuropathy and lung damage of diabetes mellitus rats. Arch Pharm Res 25:184–190CrossRefPubMed

48.

Cai EP, Lin JK (2009) Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells. J Agric Food Chem 57:9817–9827CrossRefPubMed

49.

Cai Y, Fan C, Yan J, Tian N, Ma X (2012) Effects of rutin on the expression of PPARγ in skeletal muscles of db/db mice. Planta Med 78:861–865CrossRefPubMed

50.

Kappel VD, Frederico MJ, Postal BG, Mendes CP, Cazarolli LH, Silva FR (2013) The role of calcium in intracellular pathways of rutin in rat pancreatic islets: potential insulin secretagogue effect. Eur J Pharmacol 702:264–268CrossRefPubMed

51.

Li YQ, Zhou FC, Gao F, Bian JS, Shan F (2009) Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. J Agric Food Chem 57:11463–11468CrossRefPubMed

52.

Janbaz KH, Saeed SA, Gilani AH (2002) Protective effect of rutin on paracetamol- and CCl4-induced hepatotoxicity in rodents. Fitoterapia 73:557–563CrossRefPubMed

53.

Ziaee A, Zamansoltani F, Nassiri-Asl M, Hadigol T, Ghasemi M (2011) Study of the hepatoprotective effects of rutin on acetaminophen and carbon tetrachloride-induced liver injury in rats. Pharm Sci 17:35–42

54.

Khan RA, Khan MR, Sahreen S (2012) CCl4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat. BMC Complement Altern Med 12:178PubMedCentralCrossRefPubMed

55.

Shenbagam M, Nalini N (2011) Dose response effect of rutin a dietary antioxidant on alcohol-induced prooxidant and antioxidant imbalance—a histopathologic study. Fundam Clin Pharmacol 25:493–502CrossRefPubMed

56.

Mahmoud AM (2012) Influence of rutin on biochemical alterations in hyperammonemia in rats. Exp Toxicol Pathol 64:783–789CrossRefPubMed

Title: Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid
Authors: Hossein Hosseinzadeh
Marjan Nassiri-Asl
Publication date: 01-09-2014
Publisher: Springer International Publishing
Published in: Journal of Endocrinological Investigation / Issue 9/2014
Electronic ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-014-0096-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Aim

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2014

Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms

Interest of sentinel node biopsy in apparently intrathyroidal medullary thyroid cancer: a pilot study

Hyperglycemia and duration of diabetes as risk factors for abnormal lipids: a cross sectional survey of 19,757 patients with type 2 diabetes in China

Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters

The short-term impact of vitamin D-based hip fracture prevention in older adults in the United Kingdom

Pituitary apoplexy during pregnancy: a rare, but dangerous headache

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials